These findings underscore the crucial role of the P61‐Sema3E‐Plexin D1 axis in IPF pathogenesis and suggest that targeting this pathway may hold promise for the development of novel therapeutic strategies for IPF treatment. Here, SEMA3E is linked to idiopathic pulmonary fibrosis.